Logo image of BTA

BLACKROCK LNG-TRM MUNI ADV (BTA) Stock Price, Quote, News and Overview

NYSE:BTA - New York Stock Exchange, Inc. - US09250B1035 - Currency: USD

9.97  +0.01 (+0.1%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to BTA. BTA was compared to 0 industry peers in the Unkown industry. BTA has a bad profitability rating. Also its financial health evaluation is rather negative. BTA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BTA has reported negative net income.
In multiple years BTA reported negative net income over the last 5 years.
BTA had a positive operating cash flow in each of the past 5 years.
BTA Yearly Net Income VS EBIT VS OCF VS FCFBTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M 30M

1.2 Ratios

Industry RankSector Rank
ROA -1.5%
ROE -2.4%
ROIC 2.2%
ROA(3y)0.94%
ROA(5y)0.69%
ROE(3y)1.31%
ROE(5y)0.92%
ROIC(3y)2.43%
ROIC(5y)2.41%
BTA Yearly ROA, ROE, ROICBTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20

1.3 Margins

In the last couple of years the Operating Margin of BTA has declined.
BTA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 56.07%
PM (TTM) N/A
GM 58.15%
OM growth 3Y-4.82%
OM growth 5Y-4.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.48%
GM growth 5Y-3.88%
BTA Yearly Profit, Operating, Gross MarginsBTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 200 300

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, BTA has about the same amount of shares outstanding.
BTA has about the same amout of shares outstanding than it did 5 years ago.
BTA has a better debt/assets ratio than last year.
BTA Yearly Shares OutstandingBTA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
BTA Yearly Total Debt VS Total AssetsBTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

BTA has an Altman-Z score of 1.00. This is a bad value and indicates that BTA is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 0.58 indicates that BTA is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Altman-Z 1
ROIC/WACCN/A
WACCN/A
BTA Yearly LT Debt VS Equity VS FCFBTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.91 indicates that BTA should not have too much problems paying its short term obligations.
A Quick Ratio of 1.91 indicates that BTA should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.91
Quick Ratio 1.91
BTA Yearly Current Assets VS Current LiabilitesBTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M

More info and screens

0

3. Growth

3.1 Past

BTA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.08%, which is quite impressive.
The Revenue has decreased by -6.12% in the past year.
BTA shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.67% yearly.
EPS 1Y (TTM)84.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%264.72%
Revenue 1Y (TTM)-6.12%
Revenue growth 3Y-3.59%
Revenue growth 5Y-2.67%
Sales Q2Q%-4.38%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BTA Yearly Revenue VS EstimatesBTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
BTA Yearly EPS VS EstimatesBTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BTA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BTA Price Earnings VS Forward Price EarningsBTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BTA Per share dataBTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.10%, BTA is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.27, BTA pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.1%

5.2 History

The dividend of BTA decreases each year by -1.43%.
BTA has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-1.43%
Div Incr Years0
Div Non Decr Years0
BTA Yearly Dividends per shareBTA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

BTA has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-121.07%
EPS Next 2YN/A
EPS Next 3YN/A
BTA Yearly Income VS Free CF VS DividendBTA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M 30M

More info and screens

BLACKROCK LNG-TRM MUNI ADV

NYSE:BTA (2/21/2025, 8:04:28 PM)

9.97

+0.01 (+0.1%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners22.53%
Inst Owner Change19.05%
Ins Owners0%
Ins Owner Change0.07%
Market Cap134.00M
Analysts0
Price TargetN/A
Short Float %0.09%
Short Ratio0.25
Dividend
Industry RankSector Rank
Dividend Yield 5.1%
Yearly Dividend0.61
Dividend Growth(5Y)-1.43%
DP-121.07%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-14 2025-02-14 (0.0495)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 12.14
P/FCF N/A
P/OCF N/A
P/B 0.96
P/tB 0.96
EV/EBITDA N/A
EPS(TTM)-0.25
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.82
BVpS10.43
TBVpS10.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.5%
ROE -2.4%
ROCE 2.79%
ROIC 2.2%
ROICexc 2.22%
ROICexgc 2.22%
OM 56.07%
PM (TTM) N/A
GM 58.15%
FCFM N/A
ROA(3y)0.94%
ROA(5y)0.69%
ROE(3y)1.31%
ROE(5y)0.92%
ROIC(3y)2.43%
ROIC(5y)2.41%
ROICexc(3y)2.43%
ROICexc(5y)2.42%
ROICexgc(3y)2.43%
ROICexgc(5y)2.42%
ROCE(3y)3.08%
ROCE(5y)3.06%
ROICexcg growth 3Y-3.46%
ROICexcg growth 5Y-2.82%
ROICexc growth 3Y-3.46%
ROICexc growth 5Y-2.82%
OM growth 3Y-4.82%
OM growth 5Y-4.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.48%
GM growth 5Y-3.88%
F-ScoreN/A
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.91
Quick Ratio 1.91
Altman-Z 1
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%264.72%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.12%
Revenue growth 3Y-3.59%
Revenue growth 5Y-2.67%
Sales Q2Q%-4.38%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-29.1%
EBIT growth 3Y-8.23%
EBIT growth 5Y-6.67%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y63.41%
FCF growth 3Y62.64%
FCF growth 5Y39.29%
OCF growth 1Y63.41%
OCF growth 3Y62.64%
OCF growth 5Y39.29%